{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:44:33Z","timestamp":1761561873398,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.carrev.2014.07.006","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T21:46:12Z","timestamp":1406756772000},"page":"414-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation"],"prefix":"10.1016","volume":"15","author":[{"given":"Mohan","family":"Mallikarjuna Rao Edupuganti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Marmagkiolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Cilingiroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry F.","family":"Uretsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Hakeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.carrev.2014.07.006_bb0005","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2014.07.006_bb0010","first-page":"305","article-title":"A review of warfarin dosing and monitoring","volume":"14","author":"Mariamma","year":"2001","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.carrev.2014.07.006_bb0015","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/hrt.2005.074070","article-title":"Impact of chronic oral anticoagulation on management and outcomes of patients with acute myocardial infarction: data from the RICO survey","volume":"92","author":"Oudot","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2014.07.006_bb0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ahj.2007.09.003","article-title":"Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry","volume":"155","author":"Wang","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2014.07.006_bb0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/europace\/eun369","article-title":"The Registry of the German Competence Network on Atrial Fibrillation: patient characteristics and initial management","volume":"11","author":"Nabauer","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.carrev.2014.07.006_bb0030","doi-asserted-by":"crossref","first-page":"826.e13","DOI":"10.1016\/j.amjmed.2011.11.024","article-title":"Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study","volume":"125","author":"Olesen","year":"2012","journal-title":"Am J Med"},{"issue":"22","key":"10.1016\/j.carrev.2014.07.006_bb0035","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.carrev.2014.07.006_bb0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.carrev.2014.07.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2014.03.021","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.07.006_bb0050","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/europace\/eum191","article-title":"Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence Network and the European Heart Rhythm Association","volume":"9","author":"Kirchhof","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.carrev.2014.07.006_bb0055","doi-asserted-by":"crossref","DOI":"10.5603\/CJ.a2013.0146","article-title":"Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome in the real world: data from the Berlin AFibACS Registry","author":"Maier","year":"2014","journal-title":"Cardiol J"},{"issue":"5","key":"10.1016\/j.carrev.2014.07.006_bb0060","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2013.08.005","article-title":"Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy","volume":"166","author":"Fosbol","year":"2013","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.carrev.2014.07.006_bb0065","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.amjmed.2012.04.006","article-title":"Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes","volume":"125","author":"Lopes","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.carrev.2014.07.006_bb0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.carrev.2014.07.006_bb0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2014.07.006_bb0080","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.carrev.2014.07.006_bb0085","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.carrev.2014.07.006_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","article-title":"Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation","volume":"126","author":"Lane","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.07.006_bb0095","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.carrev.2014.07.006_bb0100","first-page":"752","article-title":"Pro: antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and\/or undergo percutaneous coronary interventions","volume":"1005","author":"Rubboli","year":"2008","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.carrev.2014.07.006_bb0105","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.amjcard.2008.08.021","article-title":"Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy","volume":"102","author":"Rossini","year":"2008","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2014.07.006_bb0110","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.08-0350","article-title":"Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting","volume":"134","author":"Manzano-Fern\u00e1ndez","year":"2008","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.carrev.2014.07.006_bb0115","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehp045","article-title":"Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation","volume":"30","author":"Ruiz-Nodar","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2014.07.006_bb0120","first-page":"56","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation","volume":"1","author":"Rogacka","year":"2008","journal-title":"JACC"},{"key":"10.1016\/j.carrev.2014.07.006_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/07853890.2010.543919","article-title":"Long-term safety of drug-eluting stents in patients on warfarin treatment","volume":"44","author":"Annala","year":"2012","journal-title":"Ann Med"},{"key":"10.1016\/j.carrev.2014.07.006_bb0130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.amjcard.2011.10.046","volume":"109","author":"Nikolsky","year":"2012","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2014.07.006_bb0135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/eurheartj\/ehl488","article-title":"Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting","volume":"28","author":"Karjalainen","year":"2007","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.carrev.2014.07.006_bb0140","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11239-012-0790-y","article-title":"Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study","volume":"35","author":"Denas","year":"2013","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"10.1016\/j.carrev.2014.07.006_bb0145","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","article-title":"Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation","volume":"51","author":"Ruiz-Nodar","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.carrev.2014.07.006_bb0150","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.amjcard.2012.01.353","article-title":"Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry)","volume":"109","author":"Rubboli","year":"2012","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2014.07.006_bb0155","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.amjcard.2008.07.063","article-title":"Impact of \"nuisance\" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation","volume":"102","author":"Roy","year":"2008","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2014.07.006_bb0160","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCINTERVENTIONS.111.965186","article-title":"Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary","volume":"4","author":"Faxon","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2014.07.006_bb0165","doi-asserted-by":"crossref","first-page":"a840","DOI":"10.1136\/bmj.39533.570602.BE","article-title":"Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention","volume":"337","author":"Lip","year":"2008","journal-title":"BMJ"},{"issue":"9526","key":"10.1016\/j.carrev.2014.07.006_bb0170","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2014.07.006_bb0175","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent anticoagulation restenosis study investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.carrev.2014.07.006_bb0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2007.06.002","article-title":"Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions","volume":"50","author":"Jensen","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.carrev.2014.07.006_bb0185","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.07.006_bb0190","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"Park","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2014.07.006_bb0195","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1161\/CIRCULATIONAHA.107.743450","article-title":"Current status of percutaneous coronary intervention with drug-eluting stents in Asia","volume":"118","author":"Park","year":"2008","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.carrev.2014.07.006_bb0200","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.carrev.2014.07.006_bb0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.carrev.2014.07.006_bb0210","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2014.07.006_bb0215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2014.07.006_bb0220","first-page":"e426","volume":"123","author":"Anderson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.07.006_bb0225","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2005.02.086","article-title":"Late angiographic stent thrombosis (LAST) events with drug-eluting stents","volume":"45","author":"Ong","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2014.07.006_bb0230","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2796.2008.01989.x","article-title":"Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation","volume":"264","author":"Sarafoff","year":"2008","journal-title":"J Intern Med"},{"issue":"10","key":"10.1016\/j.carrev.2014.07.006_bb0235","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.carrev.2014.07.006_bb0240","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4244\/EIJV8I6A105","article-title":"Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score","volume":"8","author":"Smith","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2014.07.006_bb0245","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1378\/chest.09-3083","article-title":"\u201cTriple therapy\u201d rather than \u201ctriple threat\u201d: a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment","volume":"139","author":"Zhao","year":"2011","journal-title":"Chest"},{"issue":"9872","key":"10.1016\/j.carrev.2014.07.006_bb0250","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomized, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.carrev.2014.07.006_bb0255","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacc.2013.05.029","article-title":"Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention","volume":"62","author":"Lamberts","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.07.006_bb0260","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.carrev.2014.07.006_bb0265","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.carrev.2014.07.006_bb0270","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40256-013-0061-0","article-title":"New oral anticoagulants in practice: pharmacological and practical considerations","volume":"14","author":"Wang","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.carrev.2014.07.006_bb0275","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.carrev.2014.07.006_bb0280","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"127","author":"Dans","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.07.006_bb0285","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1345\/aph.1R576","article-title":"Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes","volume":"47","author":"Tsu","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.carrev.2014.07.006_bb0290","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.carrev.2014.07.006_bb0295","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1378\/chest.09-2603","article-title":"Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis","volume":"138","author":"Jamula","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.carrev.2014.07.006_bb0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjcard.2012.02.045","article-title":"Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention","volume":"110","author":"Kiviniemi","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2014.07.006_bb0305","first-page":"44","article-title":"Percutaneous coronary intervention in anticoagulated patients via radial artery access","volume":"73","author":"Helft","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2014.07.006_bb0310","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jacc.2004.04.034","article-title":"Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials","volume":"44","author":"Agostoni","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.carrev.2014.07.006_bb0315","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","volume":"31","author":"Lip","year":"2010","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.carrev.2014.07.006_bb0320","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1378\/chest.07-2627","article-title":"Outcomes associated with combined antiplatelet and anticoagulant therapy","volume":"133","author":"Johnson","year":"2008","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.carrev.2014.07.006_bb0325","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/j.1572-0241.2007.01460.x","article-title":"Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study","volume":"102","author":"Chin","year":"2007","journal-title":"Am J Gastroenterol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383891400195X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155383891400195X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:09:32Z","timestamp":1761559772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155383891400195X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S155383891400195X"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2014.07.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2014.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}